HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome
- F. Bisicchia
- R. La Rosa
- R. Russo
- M. Gussio
- S Mavilla
- M. T. Mughini
- Benedetto Maurizio Celesia
- Filippo Palermo
DOIAbstract
Purpose of the study Elderly patients (≥50 years) are increasing in the HIV population; HAART-related prolonged survival and late diagnosis of new HIV infections are possible reasons of this findings. It is debated whether older patients have a different response to HAART. The aim of this retrospective study was to evaluate efficacy of HAART and clinical outcome in a group of patients ≥50 year in comparison to a control group (<50 years-old)
Add to ORKG